Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001011438-20-000164
Filing Date
2020-07-10
Accepted
2020-07-10 16:09:52
Documents
1
Group Members
GEORGE SOROS

Document Format Files

Seq Description Document Type Size
1 form_sc13g-xeris.htm SC 13G 81604
  Complete submission text file 0001011438-20-000164.txt   83138
Mailing Address 250 WEST 55TH STREET, FLOOR 29 NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, FLOOR 29 NEW YORK NY 10019 (212) 872-1054
SOROS FUND MANAGEMENT LLC (Filed by) CIK: 0001029160 (see all company filings)

EIN.: 133914976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Subject) CIK: 0001346302 (see all company filings)

EIN.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90534 | Film No.: 201023259
SIC: 2834 Pharmaceutical Preparations